Adial Pharmaceuticals, Inc. Class of Warrant or Right, Outstanding
Adial Pharmaceuticals, Inc. (ADIL) had Class of Warrant or Right, Outstanding of 2.30 million shares as of 2023-12-31, per its 10-K filed 2024-04-01.
Discontinued › Notes
us-gaap:ClassOfWarrantOrRightOutstanding · last filed 2024-04-01
- 2023-12-31: Class of Warrant or Right, Outstanding 2.30M shares.
- 2021-10-05: Class of Warrant or Right, Outstanding 150.00K shares.
- 2018-06-30: Class of Warrant or Right, Outstanding 782.55K shares.
- 2017-06-30: Class of Warrant or Right, Outstanding 482.56K shares.
| Period end | Class of Warrant or Right, Outstanding |
|---|---|
| 2023-12-31 | 2.30M shares 10-K · filed 2024-04-01 |
| 2021-10-05 | 150.00K shares 10-K · filed 2023-03-30 |
| 2018-06-30 | 782.55K shares 10-Q · filed 2018-09-10 |
| 2017-06-30 | 482.56K shares 10-Q · filed 2018-09-10 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Phio Pharmaceuticals Corp. (PHIO) | United States | $0.012B | -0.92 |
| Scienture Holdings, Inc. (SCNX) | United States | $0.012B | -0.38 |
| KIORA PHARMACEUTICALS INC (KPRX) | United States | $0.012B | |
| BIOVIE INC. (BIVI) | United States | $0.012B | |
| Dare Bioscience, Inc. (DARE) | United States | $0.011B | |
| Aspire Biopharma Holdings, Inc. (ASBP) | United States | $0.012B | -0.60 |
| Tempest Therapeutics, Inc. (TPST) | United States | $0.013B | |
| AEON Biopharma, Inc. (AEON) | United States | $0.013B | -0.36 |
| Moleculin Biotech, Inc. (MBRX) | United States | $0.011B | |
| MetaVia Inc. (MTVA) | United States | $0.011B | -0.65 |